Voyager Therapeutics, Inc.VYGRNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 171 | 37↓78.1% | 41↑9.3% | 250↑511.2% | 80↓68.0% |
| Gross Profit | 62 | -36↓158.3% | -15↑59.2% | 158↑1162.4% | 80↓49.3% |
| Operating Income | 27 | -74↓368.8% | -51↑30.9% | 122↑340.0% | -83↓168.3% |
| Net Income | 37 | -71↓293.8% | -46↑34.8% | 132↑385.1% | -65↓149.1% |
| EBITDA | 31 | -68↓319.4% | -40↑42.1% | 126↑419.0% | -79↓162.1% |
| EPS Diluted | 0.98 | -1.75↓278.6% | -1.21↑30.9% | 2.97↑345.5% | -1.13↓138.0% |